SCHEMBL15025803

SCHEMBL15025803

CC1(C)C2CCC1(CS)C(N1CCCCC1)C2

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1297817 0.84 KDM4E (0.35) —
SCHEMBL19338346 0.84 KDM4E (0.35) —
SCHEMBL14993412 0.84 KDM4E (0.35) —
SCHEMBL15008153 0.84 KDM4E (0.35) —
Hydrochloric Acid SCHEMBL15008985 0.83 KDM4E (0.36) —
Hydrochloric Acid SCHEMBL15008983 0.83 KDM4E (0.36) —
SCHEMBL15025849 0.77 KDM4E (0.31) —
SCHEMBL12599474 0.73 CXCR3 (0.38) —
SCHEMBL23253524 0.72 CXCR3 (0.34) —
SCHEMBL22320227 0.72 CXCR3 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859765-B2 Process for the manufacture of chiral catalysts and their salts SCINOPHARM TAIWAN, LTD. (TW) 2014-10-14 — — US disclosed
US-20130150574-A1 PROCESS FOR THE MANUFACTURE OF CHIRAL CATALYSTS AND THEIR SALTS SCINOPHARM TAIWAN, LTD. (TW) 2013-06-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150574-A1 PROCESS FOR THE MANUFACTURE OF CHIRAL CATALYSTS AND THEIR SALTS TST, TMT1A, MPST SIGMAR1 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback